Form 4: Northpond Ventures Reports Conversion of Preferred Stock to Common Stock in Camp4 Therapeutics Corp (CAMP)

Sentiment:

SEC Form 4 Filing


Northpond Ventures and related entities report the conversion of preferred stock to common stock in Camp4 Therapeutics Corp following the company's initial public offering.

Summary

  • Northpond Ventures II GP, LLC, Northpond Ventures II, LP, Northpond Ventures GP, LLC, Northpond Ventures, LP, Northpond Ventures III GP, LLC, Northpond Ventures III, LP, and Michael P. Rubin filed a Form 4 regarding their holdings in Camp4 Therapeutics Corp (CAMP).
  • The report details the conversion of Series A Prime Preferred Stock and Series B Preferred Stock into common stock on October 15, 2024, following Camp4 Therapeutics' initial public offering.
  • The conversion ratio was 11.2158-for-one.
  • Northpond Ventures II, LP now holds 1,003,193 shares of common stock.
  • Northpond Ventures, LP now holds 471,415 shares of common stock.
  • Northpond Ventures III, LP now holds 763,636 shares of common stock acquired at $11 per share.
  • Michael P. Rubin, as managing member of the general partners of these entities, may be deemed to share beneficial ownership of these shares but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: This is a routine filing related to the conversion of preferred stock upon an IPO. It doesn't inherently indicate positive or negative sentiment, but rather reflects a procedural step.

Industry Context

Form 4 filings are standard disclosures required by the SEC when significant changes in ownership occur, particularly involving company insiders and major shareholders. This filing reflects the conversion of preferred shares to common shares in connection with Camp4 Therapeutics' IPO, a common occurrence.

Stakeholder Impact

  • The conversion of preferred stock to common stock impacts shareholders by increasing the number of outstanding common shares.
  • This conversion was triggered by the IPO and is a standard part of the IPO process.

Key Dates

DateDescription
10/15/2024Conversion of Preferred Stock to Common Stock
10/17/2024Date of Form 4 Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.